| Patent | Date |
|---|
Anti-C5A antibodies
Grant 11,407,821 - Rother , et al. August 9, 2 | 2022-08-09 |
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
Grant 11,112,402 - Movalia , et al. September 7, 2 | 2021-09-07 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20200392216 - BELL; Leonard ; et al. | 2020-12-17 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 10,703,809 - Bell , et al. | 2020-07-07 |
Anti-c5a Antibodies
App 20200207842 - ROTHER; Russell P. ; et al. | 2020-07-02 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20200199211 - BELL; Leonard ; et al. | 2020-06-25 |
Methods For Treating Complement-associated Disorders
App 20200140531 - ROTHER; Russell P. ; et al. | 2020-05-07 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 10,590,189 - Bell , et al. | 2020-03-17 |
Methods And Compositions For Treating Complement-associated Disorders
App 20200071391 - Rother; Russell P. | 2020-03-05 |
Anti-C5a antibodies
Grant 10,450,370 - Rother , et al. Oc | 2019-10-22 |
Prolongation Of Survival Of An Allograft By Inhibiting Complement Activity
App 20190309053 - ROTHER; Russell P. ; et al. | 2019-10-10 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20190025293 - Movalia; Mayur ; et al. | 2019-01-24 |
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
Grant 10,126,293 - Movalia , et al. November 13, 2 | 2018-11-13 |
METHODS OF PRODUCING ANTI-C5a ANTIBODIES
App 20180273612 - ROTHER; Russell P. ; et al. | 2018-09-27 |
Methods of producing anti-C5a antibodies
Grant 9,963,503 - Rother , et al. May 8, 2 | 2018-05-08 |
Therapeutic methods using anti-CD200 antibodies
Grant 9,862,767 - Rother , et al. January 9, 2 | 2018-01-09 |
Methods For Treating Complement-associated Disorders
App 20170369562 - ROTHER; Russell P. ; et al. | 2017-12-28 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20170349652 - BELL; Leonard ; et al. | 2017-12-07 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20170285013 - MOVALIA; Mayur ; et al. | 2017-10-05 |
Methods for treating complement-associated disorders
Grant 9,771,418 - Rother , et al. September 26, 2 | 2017-09-26 |
Prolongation Of Survival Of An Allograft By Inhibiting Complement Activity
App 20170267751 - ROTHER; Russell P. ; et al. | 2017-09-21 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,732,149 - Bell , et al. August 15, 2 | 2017-08-15 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,725,504 - Bell , et al. August 8, 2 | 2017-08-08 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,718,880 - Bell , et al. August 1, 2 | 2017-08-01 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant RE46,323 - Rother , et al. February 28, 2 | 2017-02-28 |
Methods For Treating Complement-associated Disorders
App 20170015740 - Rother; Russell P. ; et al. | 2017-01-19 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20170015741 - BELL; Leonard ; et al. | 2017-01-19 |
Anti-c5a Antibodies
App 20160376357 - ROTHER; Russell P. ; et al. | 2016-12-29 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20160376355 - BELL; Leonard ; et al. | 2016-12-29 |
Methods For Treating Complement-associated Disorders
App 20160355580 - ROTHER; Russell P. ; et al. | 2016-12-08 |
Methods For Treating Complement-associated Disorders
App 20160355579 - Rother; Russell P. ; et al. | 2016-12-08 |
Methods And Compositions For Treating Complement-associated Disorders
App 20160319004 - Rother; Russell P. ; et al. | 2016-11-03 |
Methods of treating complement-associated disorders with anti-C5a antibodies
Grant 9,469,690 - Rother , et al. October 18, 2 | 2016-10-18 |
Methods and compositions for treating complement-associated disorders
Grant 9,447,176 - Rother , et al. September 20, 2 | 2016-09-20 |
Nucleic Acids Encodng Anti-c5a Antibodies
App 20160264654 - ROTHER; Russell P. ; et al. | 2016-09-15 |
Nucleic acids encodng anti-C5A antibodies
Grant 9,434,784 - Rother , et al. September 6, 2 | 2016-09-06 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20160244516 - BELL; Leonard ; et al. | 2016-08-25 |
Anti-c5a Antibodies
App 20160207997 - ROTHER; Russell P. ; et al. | 2016-07-21 |
Methods and compositions for the treatment of antibody mediated neuropathies
Grant 9,388,235 - Halstead , et al. July 12, 2 | 2016-07-12 |
Anti-C5a antibodies
Grant 9,371,378 - Rother , et al. June 21, 2 | 2016-06-21 |
Anti-c5a Antibodies
App 20160159892 - ROTHER; Russell P. ; et al. | 2016-06-09 |
Nucleic acids encoding anti-C5a antibodies
Grant 9,309,310 - Rother , et al. April 12, 2 | 2016-04-12 |
Nucleic Acides Encoding Anti-c5a Antibodies
App 20160053004 - Rother; Russell P. ; et al. | 2016-02-25 |
Therapeutic Methods Using Anti-cd200 Antibodies
App 20160009803 - ROTHER; Russell P. ; et al. | 2016-01-14 |
Methods of treating complement-associated disorders with anti-C5a antibodies
Grant 9,221,901 - Rother , et al. December 29, 2 | 2015-12-29 |
Therapeutic methods using anti-CD200 antibodies
Grant 9,085,623 - Rother , et al. July 21, 2 | 2015-07-21 |
Anti-c5a Antibodies And Methods For Using The Antibodies
App 20150183859 - ROTHER; Russell P. ; et al. | 2015-07-02 |
Anti-C5a antibodies
Grant 9,011,852 - Rother , et al. April 21, 2 | 2015-04-21 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20140286962 - MOVALIA; Mayur ; et al. | 2014-09-25 |
Antibodies Having Reduced Immunogenicity In A Human
App 20140206849 - Rother; Russell P. ; et al. | 2014-07-24 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant 8,637,014 - Rother , et al. January 28, 2 | 2014-01-28 |
ANTI-C5a ANTIBODIES AND METHODS FOR USING THE ANTIBODIES
App 20130224187 - Rother; Russell P. ; et al. | 2013-08-29 |
Therapeutic Methods Using Anti-cd200 Antibodies
App 20130189258 - Rother; Russell P. ; et al. | 2013-07-25 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20130045192 - Movalia; Mayur ; et al. | 2013-02-21 |
Antibodies To Ox-2/cd200 And Uses Thereof In Inhibiting Immune Responses
App 20120321625 - Rother; Russell P. ; et al. | 2012-12-20 |
Method Of Treating Hemolytic Disease
App 20120308559 - Bell; Leonard ; et al. | 2012-12-06 |
Hybrid antibodies
Grant 8,282,924 - Rother , et al. October 9, 2 | 2012-10-09 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20120237515 - Bell; Leonard ; et al. | 2012-09-20 |
Methods And Compositions For Treating Complement-associated Disorders
App 20120225056 - Rother; Russell P. ; et al. | 2012-09-06 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant 8,252,285 - Rother , et al. August 28, 2 | 2012-08-28 |
Engineered Antibodies With Reduced Immunogenicity And Methods Of Making
App 20110313134 - Rother; Russell P. | 2011-12-22 |
Hybrid antibodies
Grant 8,067,167 - Rother , et al. November 29, 2 | 2011-11-29 |
Hybrid antibodies
Grant 7,927,817 - Rother , et al. April 19, 2 | 2011-04-19 |
Method Of Treating Hemolytic Disease
App 20110086040 - Bell; Leonard ; et al. | 2011-04-14 |
Antibodies To Ox-2/cd200 And Uses Thereof In Inhibiting Immune Responses
App 20100291085 - Rother; Russell P. ; et al. | 2010-11-18 |
Methods And Compositions For The Treatment Of Antibody Mediated Neuropathies
App 20100143343 - Halstead; Susan ; et al. | 2010-06-10 |
Prolongation of Survival of an Allograft by Inhibiting Complement Activity
App 20100135992 - Rother; Russell P. ; et al. | 2010-06-03 |
Method Of Treating Hemolytic Disease
App 20100068202 - Bell; Leonard ; et al. | 2010-03-18 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20090220508 - Bell; Leonard ; et al. | 2009-09-03 |
Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
App 20090041764 - Spuler; Simone ; et al. | 2009-02-12 |
Prolongation of survival of an allograft by inhibiting complement activity
App 20090028850 - Rother; Russell P. ; et al. | 2009-01-29 |
Hybrid antibodies
Grant 7,399,594 - Rother , et al. July 15, 2 | 2008-07-15 |
De-Immunized Anti-Cd3 Antibody
App 20070292416 - Rother; Russell P. ; et al. | 2007-12-20 |
Methods of treating hemolytic anemia
App 20070116710 - Bell; Leonard ; et al. | 2007-05-24 |
Stratification of patient populations having or suspected of having rheumatoid arthritis
App 20050221382 - Rother, Russell P. | 2005-10-06 |
Method of treating hemolytic disease
App 20050191298 - Bell, Leonard ; et al. | 2005-09-01 |
Method of treating hemolytic disease
App 20050169921 - Bell, Leonard ; et al. | 2005-08-04 |
Hybrid antibodies
App 20030219861 - Rother, Russell P. ; et al. | 2003-11-27 |
Methods For The Preparation Of Retroviral Particles And Cell Lines Deficient In The Alpha-galactosyl Epitope
App 20020045247 - ROTHER, RUSSELL P. ; et al. | 2002-04-18 |
C5-specific antibodies for the treatment of inflammatory diseases
Grant 6,355,245 - Evans , et al. March 12, 2 | 2002-03-12 |
Retroviral transduction of cells using soluble complement inhibitors
Grant 5,562,904 - Rother , et al. October 8, 1 | 1996-10-08 |
| 